ME News report, June 25 (UTC+8): According to monitoring by Beating, a consortium named Intercept has been launched by enterprises and charitable organizations including Stripe, Anthropic, and the OpenAI Foundation, announcing an investment of $500 million to develop antiviral drugs and promote air purification technologies. The Intercept initiative is co-led by Nan Ransohoff, Head of Public Products at Stripe, with additional funding from the nonprofit Flu Lab, individual employees of Jane Street Trading, and charitable organizations under Bill Gates. In drug development, Intercept aims to provide financial support to establish human clinical proof-of-concept for broad-spectrum vaccines, sprays, and pills targeting multiple respiratory viruses such as the common cold, COVID-19, and influenza, after which large pharmaceutical companies will take over further development. Regarding air purification technologies, efforts focus on scaling existing solutions capable of blocking or eliminating airborne pathogens and building a potential buyer network including JPMorgan Chase, Mastercard, Meta, Stripe, and Anthropic. Respiratory infections impose a massive burden on global public health and economic productivity. Estimates indicate that the COVID-19 pandemic claimed approximately 14.9 million lives in 2020 and 2021. Research by the UK Health Economics Institute shows that respiratory infections cost UK businesses about £44 billion annually. Regarding the Intercept initiative, Jacco Boon, a respiratory virus expert at the University of Washington, noted that while the direction of combating respiratory pathogens is clear, launching too many parallel initiatives simultaneously makes actual outcomes difficult to predict. Ann Falsey, an infectious disease expert at the University of Rochester Medical Center, also stated that preventing respiratory pathogens across the entire viral spectrum remains a scientifically challenging endeavor. (Source: BlockBeats)
Anthropic, OpenAI, and Stripe invest $500 million to combat respiratory infections
KuCoinFlashShare
Summary
On-chain news: On June 25 (UTC+8), Anthropic, OpenAI, and Stripe announced a $500 million investment in the Intercept initiative to develop antiviral drugs and air purification technologies. Co-led by Stripe’s Nan Ransohoff, the project includes support from Flu Lab, Jane Street, and Bill Gates’ charity, targeting colds, flu, and COVID-19 through clinical trials and technology scaling. JPMorgan, Meta, and others are potential buyers.
Crypto news: Respiratory infections cost the UK £44 billion annually. Some experts argue that the initiative’s broad focus could dilute its impact.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.